March 22, 2019

FDA Approves Large-Scale Commercial Production of Andexxa

By Jennifer Barrett, Associate Editor
Published Online: Monday, Jan 07, 2019

References
  1. US Food and Drug Administration Approves Portola Pharmaceuticals’ Prior Approval Supplement for Andexxa Generation 2 Manufacturing Process [news release]. Portola’s website. http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=2381753&rel=0" . Accessed January 2, 2019.
  2. US FDA Approves Portola Pharmaceuticals’ Andexxa, First and Only Antidote for the Reversal of Factor Xa Inhibitors [news release]. Portola’s website. http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsroomArticle&ID=2347018&rel=0" . Accessed January 2, 2019.


About the Specialty Pharmacy Times Industry Guide

The Specialty Pharmacy Times Industry Guide includes comprehensive editorial content relative to all specialty pharmacy stakeholders. Content includes information relative to market trends, commercialization, distribution, order to cash, HUB Services, managed care strategies and DIR fees. The guide also includes profiles, and a complete list of stakeholders along the patient journey: specialty pharmacies, wholesaler distributors, manufacturers, support services, group purchasing, and trade associations.

Sign Up for the Industry Guide Newsletter

Copyright © 2006-2018 Pharmacy & Healthcare Communications, LLC
All Rights Reserved

About Us